$21.00Average Price Target
The highest estimate is 28.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
This list is based on the watchlists of people on Stock Events who follow EVMN.BOATS. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
FAQs
What is Evommune stock price today?▼
The current price of EVMN.BOATS is $6.46 USD — it has increased by +4.7% in the past 24 hours. Watch Evommune stock price performance more closely on the chart.
What is Evommune stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Evommune stocks are traded under the ticker EVMN.BOATS.
What is Evommune market cap?▼
Today Evommune has the market capitalization of 234.45M
When is the next Evommune earnings date?▼
Evommune is going to release the next earnings report on December 10, 2026.
What were Evommune earnings last quarter?▼
EVMN.BOATS earnings for the last quarter are -0.89 USD per share, whereas the estimation was -0.66 USD resulting in a -33.94% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Evommune revenue for the last year?▼
Evommune revenue for the last year amounts to 13M USD.
What is Evommune net income for the last year?▼
EVMN.BOATS net income for the last year is -68.87M USD.
In which sector is Evommune located?▼
Evommune operates in the Other sector.
When did Evommune complete a stock split?▼
Evommune has not had any recent stock splits.